Literature DB >> 12189209

Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.

Hideki Sakahira1, Peter Breuer, Manajit K Hayer-Hartl, F Ulrich Hartl.   

Abstract

The formation of insoluble protein aggregates in neurons is a hallmark of neurodegenerative diseases caused by proteins with expanded polyglutamine (polyQ) repeats. However, the mechanistic relationship between polyQ aggregation and its toxic effects on neurons remains unclear. Two main hypotheses have been put forward for how polyQ expansions may cause cellular dysfunction. In one model neurotoxicity results from the ability of polyQ-expanded proteins to recruit other important cellular proteins with polyQ stretches into the aggregates. In the other model, aggregating polyQ proteins partially inhibit the ubiquitin-proteasome system for protein degradation. These two mechanisms are not exclusive but may act in combination. In general, protein misfolding and aggregation are prevented by the machinery of molecular chaperones. Some chaperones such as the members of the Hsp70 family also modulate polyQ aggregation and suppress its toxicity. These recent findings suggest that an imbalance between the neuronal chaperone capacity and the production of potentially dangerous polyQ proteins may trigger the onset of polyQ disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12189209      PMCID: PMC139902          DOI: 10.1073/pnas.182426899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  83 in total

1.  Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo.

Authors:  H Ikeda; M Yamaguchi; S Sugai; Y Aze; S Narumiya; A Kakizuka
Journal:  Nat Genet       Date:  1996-06       Impact factor: 38.330

2.  Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70.

Authors:  B Bercovich; I Stancovski; A Mayer; N Blumenfeld; A Laszlo; A L Schwartz; A Ciechanover
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

3.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

4.  Involvement of the molecular chaperone Ydj1 in the ubiquitin-dependent degradation of short-lived and abnormal proteins in Saccharomyces cerevisiae.

Authors:  D H Lee; M Y Sherman; A L Goldberg
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

5.  Disruption of CREB function in brain leads to neurodegeneration.

Authors:  Theo Mantamadiotis; Thomas Lemberger; Susanne C Bleckmann; Heidrun Kern; Oliver Kretz; Ana Martin Villalba; François Tronche; Christoph Kellendonk; Daniel Gau; Josef Kapfhammer; Christiane Otto; Wolfgang Schmid; Günther Schütz
Journal:  Nat Genet       Date:  2002-04-22       Impact factor: 38.330

6.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases.

Authors:  M F Perutz; T Johnson; M Suzuki; J T Finch
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

Review 7.  Chaperoning brain degeneration.

Authors:  Nancy M Bonini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes.

Authors:  M Latterich; K U Fröhlich; R Schekman
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

Review 9.  Hsp70 and aging.

Authors:  A R Heydari; R Takahashi; A Gutsmann; S You; A Richardson
Journal:  Experientia       Date:  1994-11-30

10.  Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes.

Authors:  J Nasir; S B Floresco; J R O'Kusky; V M Diewert; J M Richman; J Zeisler; A Borowski; J D Marth; A G Phillips; M R Hayden
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

View more
  69 in total

1.  Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.

Authors:  Erwann Rousseau; Benjamin Dehay; Léa Ben-Haïem; Yvon Trottier; Michel Morange; Anne Bertolotti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

Review 2.  Drug targets from genetics: α-synuclein.

Authors:  Karin M Danzer; Pamela J McLean
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

3.  Hsp70 chaperones accelerate protein translocation and the unfolding of stable protein aggregates by entropic pulling.

Authors:  Paolo De Los Rios; Anat Ben-Zvi; Olga Slutsky; Abdussalam Azem; Pierre Goloubinoff
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

4.  The yeast HtrA orthologue Ynm3 is a protease with chaperone activity that aids survival under heat stress.

Authors:  Nirmala Padmanabhan; Lars Fichtner; Achim Dickmanns; Ralf Ficner; Jörg B Schulz; Gerhard H Braus
Journal:  Mol Biol Cell       Date:  2008-10-22       Impact factor: 4.138

Review 5.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.

Authors:  Massimo Stefani; Christopher M Dobson
Journal:  J Mol Med (Berl)       Date:  2003-08-27       Impact factor: 4.599

6.  Nuclear aggregation of polyglutamine-expanded ataxin-3: fragments escape the cytoplasmic quality control.

Authors:  Peter Breuer; Annette Haacke; Bernd O Evert; Ullrich Wüllner
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

7.  Identification of a consensus motif in substrates bound by a Type I Hsp40.

Authors:  Pradeep Kota; Daniel W Summers; Hong-Yu Ren; Douglas M Cyr; Nikolay V Dokholyan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-22       Impact factor: 11.205

Review 8.  Therapeutic perspectives for the treatment of Huntington's disease: treating the whole body.

Authors:  Bronwen Martin; Erin Golden; Alex Keselman; Matthew Stone; Mark P Mattson; Josephine M Egan; Stuart Maudsley
Journal:  Histol Histopathol       Date:  2008-02       Impact factor: 2.303

9.  Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model.

Authors:  Scoty M Hearst; Qingmei Shao; Mariper Lopez; Drazen Raucher; Parminder J S Vig
Journal:  Cerebellum       Date:  2014-10       Impact factor: 3.847

10.  Mutant Huntingtin reduces HSP70 expression through the sequestration of NF-Y transcription factor.

Authors:  Tomoyuki Yamanaka; Haruko Miyazaki; Fumitaka Oyama; Masaru Kurosawa; Chika Washizu; Hiroshi Doi; Nobuyuki Nukina
Journal:  EMBO J       Date:  2008-02-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.